Lateral Flow Assay

Capillary action pulls the liquid sample through the strip’s porous material without requiring pumps or external power. As the liquid advances, it carries target molecules and labeled binding molecules toward the immobilized capture zones. Consistent movement is essential because incomplete or uneven flow can prevent the test and control lines from forming reliably.

Labeled binding molecules recognize the biological target as the sample moves through the strip. The resulting target-associated complexes are retained at specific immobilized capture zones, where their accumulated label produces a visible test line. This arrangement links molecular recognition to a location-specific signal, allowing the assay to indicate whether the target was detected.

The control line provides evidence that the sample moved through the strip and that the assay operated as intended. It does not serve the same interpretive role as the target-related test line. A visible control signal therefore helps distinguish a functioning negative result from a test in which flow or assay performance was inadequate.

Improved sensitivity can be pursued through changes in materials and through signal amplification, both identified as active areas of lateral flow assay innovation. Visual lines provide a rapid qualitative readout, whereas quantitative readers can analyze signal intensity to generate more measured results. These developments aim to broaden detection capability while preserving the platform’s portability.

A user applies the liquid sample to the assay, allows it to migrate through the porous strip, and waits for interactions between targets, labeled binding molecules, and immobilized capture zones. The resulting test and control lines are then read, with the control line used to verify proper flow and test function. Minimal equipment supports this workflow.

This approach is particularly useful when testing must occur rapidly, outside centralized laboratories, or with limited equipment. Its portability, low cost, simple operation, and visual readout support decentralized and point-of-care settings. Researchers can adapt it for detecting proteins, nucleic acids, pathogens, or other biomarkers when quick screening is more important than complex instrumentation.

In bioengineering, these assays can indicate the presence of selected biological targets, including proteins, nucleic acids, pathogens, and other biomarkers. Their compact format connects biological recognition with an accessible readout, making them useful for developing decentralized diagnostic systems. Quantitative readers, improved materials, and signal amplification are expanding the kinds of measurements and applications being explored.